YEAR
- 2016.08.04 Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, Mochizuki M, Miyabe A, Araki M, Hara KY, Shimatani Z, Kondo A.Science. 2016 09 16;353(6305). doi: 10.1126/science.aaf8729
- 2013.07.29 Targeting cancer cells resistant to hypoxia and nutrient starvation to improve anti-angiogeneic therapy. Osawa T, Shibuya M.Cell Cycle. 2013 Aug 15;12(16):2519-20. doi: 10.4161/cc.25729
- 2001.07.12 Targets of transcriptional regulation by transforming growth factor-beta: expression profile analysis using oligonucleotide arrays. Akiyoshi S, Ishii M, Nemoto N, Kawabata M, Aburatani H, Miyazono K.Jpn. J. Cancer Res. 2001 Mar;92(3):257-68. doi: 10.1111/j.1349-7006.2001.tb01090.x
- 2002.11.26 Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells. Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H, Miyazono K.J. Cell. Physiol. 2002 Dec;193(3):299-318. doi: 10.1002/jcp.10170
- 2010.11.03 Testis-specific protein on Y chromosome (TSPY) represses the activity of the androgen receptor in androgen-dependent testicular germ-cell tumors. Akimoto C, Ueda T, Inoue K, Yamaoka I, Sakari M, Obara W, Fujioka T, Nagahara A, Nonomura N, Tsutsumi S, Aburatani H, Miki T, Matsumoto T, Kitagawa H, Kato S.Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19891-6. doi: 10.1073/pnas.1010307107. Epub 2010 Nov 1. Retraction in: Akimoto C, Ueda T, Inoue K, Yamaoka I, Sakari M, Obara W, Fujioka T, Nagahara A, Nonomura N, Tsutsumi S, Aburatani H, Miki T, Matsumoto T, Kitagawa H, Kato S. Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2398.
- 2016.12.06 TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection. Namba-Fukuyo H, Funata S, Matsusaka K, Fukuyo M, Rahmutulla B, Mano Y, Fukayama M, Aburatani H, Kaneda A.Oncotarget. 2016 Dec 06;7(49):81512-81526. doi: 10.18632/oncotarget.13130
- 2006.11.06 Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H.J. Exp. Med. 2006 Nov 27;203(12):2673-82. doi: 10.1084/jem.20061775
- 2019.11.12 The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension. Morikawa M, Mitani Y, Holmborn K, Kato T, Koinuma D, Maruyama J, Vasilaki E, Sawada H, Kobayashi M, Ozawa T, Morishita Y, Bessho Y, Maeda S, Ledin J, Aburatani H, Kageyama R, Maruyama K, Heldin CH, Miyazono K.Sci Signal. 2019 11 12;12(607). doi: 10.1126/scisignal.aay4430
CLOSE